The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
HLA-DPB1 protein mutant form binds to Beryllium HLA-DPB1 gene polymorphism results in increased susceptibility to Beryllium; HLA-DPB1 gene SNP results in increased susceptibility to Beryllium; HLA-DPB1 protein mutant form results in increased susceptibility to Beryllium
Beryllium results in increased expression of TNF mRNA TNF promoter polymorphism results in increased susceptibility to Beryllium Beryllium results in increased secretion of TNF protein
Lithium results in increased phosphorylation of AKT1 protein Lithium results in increased expression of AKT1 mRNA; Lithium results in increased expression of AKT1 protein
Lithium inhibits the reaction [APP protein binds to APP protein] Lithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein]
Lithium inhibits the reaction [Deamino Arginine Vasopressin results in increased expression of AQP2 mRNA]; Lithium inhibits the reaction [Deamino Arginine Vasopressin results in increased expression of AQP2 protein]; PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of AQP2 protein] [Aldosterone co-treated with Lithium] affects the expression of AQP2 protein; [Spironolactone co-treated with Lithium] affects the expression of AQP2 protein; Hydrochlorothiazide inhibits the reaction [Lithium results in decreased expression of AQP2 protein] Lithium results in decreased expression of AQP2 mRNA; Lithium results in decreased expression of AQP2 protein Lithium results in increased expression of AQP2 protein
Lithium results in decreased expression of ATP1A1 mRNA Lithium results in increased expression of ATP1A1 protein Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 mRNA]; Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 protein]
Lithium affects the expression of AVP protein Lithium results in increased expression of AVP protein Chlorpromazine inhibits the reaction [Lithium results in increased expression of AVP protein]
[Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Paraquat results in increased expression of BAX mRNA]; [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Paraquat results in increased expression of BAX protein]; [Lithium Chloride results in increased abundance of Lithium] which results in decreased expression of BAX mRNA; [Lithium Chloride results in increased abundance of Lithium] which results in decreased expression of BAX protein; Lithium inhibits the reaction [sodium arsenite affects the localization of BAX protein]; Lithium inhibits the reaction [sodium arsenite promotes the reaction [BAX protein binds to BAX protein]] Lithium inhibits the reaction [Cadmium results in increased expression of BAX protein]; Lithium inhibits the reaction [Methamphetamine results in increased expression of BAX protein]; Lithium inhibits the reaction [Morphine results in increased expression of BAX mRNA] Lithium results in decreased expression of BAX mRNA
[Lithium Chloride results in increased abundance of Lithium] promotes the reaction [Paraquat results in increased expression of BCL2 mRNA]; [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of BCL2 mRNA; [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of BCL2 protein; [Paraquat co-treated with [Lithium Chloride results in increased abundance of Lithium]] results in increased expression of BCL2 protein; Lithium inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA] Lithium results in increased expression of BCL2; Lithium results in increased expression of BCL2 mRNA; Lithium results in increased expression of BCL2 protein Lithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein]; Lithium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]; Lithium inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]; Lithium inhibits the reaction [Morphine results in decreased expression of BCL2 mRNA]
BDNF gene polymorphism affects the susceptibility to Lithium [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Paraquat results in decreased expression of BDNF mRNA]; [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Paraquat results in decreased secretion of BDNF protein]; [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of BDNF mRNA; [Lithium Chloride results in increased abundance of Lithium] which results in increased secretion of BDNF protein Lithium results in increased expression of BDNF mRNA; Lithium results in increased expression of BDNF protein Lithium results in decreased expression of BDNF mRNA Diazepam inhibits the reaction [Lithium results in increased expression of BDNF mRNA]; Lithium inhibits the reaction [Dextroamphetamine results in decreased expression of BDNF protein]; Lithium inhibits the reaction [Ouabain results in decreased expression of BDNF protein] BDNF protein results in increased susceptibility to Lithium
[Pilocarpine co-treated with Lithium] results in increased expression of CASP12 mRNA; [Pilocarpine co-treated with Lithium] results in increased expression of CASP12 protein; Edaravone inhibits the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of CASP12 protein]
[Pilocarpine co-treated with Lithium] results in increased activity of CASP3 protein; Lithium inhibits the reaction [Cadmium results in increased expression of CASP3 protein]; Lithium inhibits the reaction [Colchicine results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased activity of CASP3 protein] Lithium results in decreased activity of CASP3 protein [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Paraquat results in increased activity of CASP3 protein]; Lithium inhibits the reaction [Monensin results in increased activity of CASP3 protein]; Lithium inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]
Lithium inhibits the reaction [Camptothecin results in increased activity of CASP8 protein]; Lithium inhibits the reaction [Etoposide results in increased activity of CASP8 protein]
Lithium results in increased expression of CTNNB1 protein Lithium results in decreased expression of CTNNB1 mRNA Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA]; Lithium results in increased expression of and affects the localization of CTNNB1 protein Lithium affects the localization of CTNNB1 protein
Lithium inhibits the reaction [Camptothecin results in increased expression of and affects the localization of FAS protein]; Lithium inhibits the reaction [Etoposide results in increased expression of and affects the localization of FAS protein]
Lithium results in increased expression of FOS mRNA Lithium results in increased expression of FOS protein [Pilocarpine co-treated with Lithium] results in increased expression of FOS protein; Lithium promotes the reaction [Pilocarpine results in increased expression of FOS mRNA]
Lithium results in decreased expression of GRIK2 mRNA; Lithium results in decreased expression of GRIK2 protein [Lithium co-treated with Pilocarpine] results in increased expression of GRIK2 mRNA
Lithium results in increased expression of GSK3A protein Lithium promotes the reaction [sodium arsenite results in increased phosphorylation of GSK3A protein]
Lithium results in increased phosphorylation of GSK3B protein Lithium inhibits the reaction [GSK3B protein binds to TP53 protein]; Lithium promotes the reaction [sodium arsenite results in increased phosphorylation of GSK3B protein]; Magnesium affects the reaction [Lithium results in decreased activity of GSK3B protein] Lithium results in decreased phosphorylation of GSK3B protein Lithium results in increased phosphorylation of and results in decreased activity of GSK3B protein Lithium results in increased expression of GSK3B mRNA; Lithium results in increased expression of GSK3B protein [Lithium results in decreased activity of GSK3B protein] which results in increased activity of MTOR protein; [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein; Lithium results in increased phosphorylation of and results in decreased activity of GSK3B protein
Folic Acid inhibits the reaction [Lithium affects the expression of HHEX mRNA]; Inositol promotes the reaction [Folic Acid inhibits the reaction [Lithium affects the expression of HHEX mRNA]]
Lithium results in increased expression of HMOX1 protein [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of HMOX1 mRNA
[Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 mRNA; [Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 protein; Edaravone promotes the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of HSPA5 protein] Lithium results in increased expression of HSPA5 mRNA; Lithium results in increased expression of HSPA5 protein
[Pilocarpine co-treated with Lithium] results in increased expression of IL1B mRNA; [Pilocarpine co-treated with Lithium] results in increased expression of IL1B protein; Edaravone inhibits the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of IL1B mRNA]; Edaravone inhibits the reaction [[Pilocarpine co-treated with Lithium] results in increased expression of IL1B protein] Lithium results in increased expression of IL1B protein Lithium inhibits the reaction [Olanzapine results in increased expression of IL1B mRNA]; Lithium inhibits the reaction [Olanzapine results in increased expression of IL1B protein] Lithium results in decreased expression of IL1B mRNA
Lithium inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Lithium inhibits the reaction [Olanzapine results in increased expression of IL6 mRNA]; Lithium inhibits the reaction [Olanzapine results in increased expression of IL6 protein] Lithium results in increased expression of IL6 mRNA
[Lithium co-treated with Pilocarpine] results in increased expression of JUN protein; Lithium promotes the reaction [Pilocarpine results in increased expression of JUN mRNA]
[Lithium results in increased phosphorylation of and results in increased activity of MAP3K8 protein] which results in increased phosphorylation of MAP2K1 protein
Lithium results in increased degradation of MAP3K8 protein alternative form [Lithium results in increased degradation of NFKB1 protein] inhibits the reaction [NFKB1 protein binds to MAP3K8 protein]; [Lithium results in increased phosphorylation of and results in increased activity of MAP3K8 protein] which results in increased phosphorylation of MAP2K1 protein; Lithium promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAP3K8 protein]; Lithium results in increased phosphorylation of and results in increased activity of MAP3K8 protein
Lithium promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Lithium results in increased phosphorylation of and results in increased activity of MAPK1 protein Lithium results in increased expression of MAPK1 protein Lithium results in increased activity of MAPK1 protein Lithium results in increased phosphorylation of MAPK1 protein
Lithium promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Lithium results in increased phosphorylation of and results in increased activity of MAPK3 protein Lithium results in increased activity of MAPK3 protein
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR21 mRNA; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR21 mRNA]
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR29B1 mRNA; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR29B1 mRNA]
[Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Paraquat results in increased expression of MIR34A mRNA]; [Lithium Chloride results in increased abundance of Lithium] which results in decreased expression of MIR34A mRNA
Lithium results in increased activity of NFE2L2 protein [Lithium Chloride results in increased abundance of Lithium] which affects the localization of NFE2L2 protein; [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of NFE2L2 mRNA [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein
Lithium results in increased degradation of NFKB1 protein [Lithium results in increased degradation of NFKB1 protein] inhibits the reaction [NFKB1 protein binds to MAP3K8 protein]; Lithium inhibits the reaction [Lipopolysaccharides results in increased activity of and results in increased localization of NFKB1 protein]
[Pilocarpine co-treated with Lithium] results in increased expression of NOS1 protein; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased expression of NOS1 protein] Lithium results in increased expression of NOS1 mRNA
[Pilocarpine co-treated with Lithium] results in increased expression of NOS2 protein; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased expression of NOS2 protein]
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of NOS3 protein; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of NOS3 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein] Lithium inhibits the reaction [Dexamethasone affects the localization of and results in increased activity of NR3C1 protein]
PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of AQP2 protein]; PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of SLC14A2 protein] PRKCA gene mutant form results in decreased susceptibility to Lithium PRKCA gene results in increased susceptibility to Lithium
Lithium inhibits the reaction [Lipopolysaccharides results in increased activity of and results in increased localization of RELA protein] Lithium results in increased activity of RELA protein
Lithium affects the expression of SCNN1G protein [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Lithium
Lithium inhibits the reaction [SLC13A2 protein results in increased uptake of Citric Acid] Lithium promotes the reaction [SLC13A2 protein results in increased uptake of Citric Acid]
Lithium results in decreased expression of SLC14A2 protein PRKCA gene mutant form inhibits the reaction [Lithium results in decreased expression of SLC14A2 protein]
Lithium results in decreased expression of SLC9A1 mRNA Lithium results in increased activity of SLC9A1 protein Phloretin inhibits the reaction [SLC9A1 protein alternative form affects the transport of [Sodium co-treated with Lithium]]; SLC9A1 protein alternative form affects the transport of [Sodium co-treated with Lithium]
[Pilocarpine co-treated with Lithium] results in increased expression of TAC1 mRNA; [Pilocarpine co-treated with Lithium] results in increased expression of TAC1 protein modified form; Dizocilpine Maleate inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased expression of TAC1 protein modified form]
Lithium inhibits the reaction [Cadmium results in increased expression of TNF protein] Lithium inhibits the reaction [Olanzapine results in increased expression of TNF mRNA]; Lithium inhibits the reaction [Olanzapine results in increased expression of TNF protein] Lithium results in decreased expression of TNF mRNA
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of TNNI3 protein; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of TNNI3 protein]
TP53 affects the reaction [Lithium results in increased expression of CDKN1A protein] Lithium inhibits the reaction [GSK3B protein binds to TP53 protein]; Lithium inhibits the reaction [sodium arsenite results in increased expression of and affects the localization of TP53 protein]
Lithium results in increased expression of VEGFA mRNA; Lithium results in increased expression of VEGFA protein Lithium results in decreased expression of VEGFA mRNA
trimethyltin results in increased expression of AIF1 mRNA; trimethyltin results in increased expression of AIF1 protein magnolol inhibits the reaction [trimethyltin results in increased expression of AIF1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BAD protein modified form]]; rottlerin inhibits the reaction [trimethyltin results in decreased expression of BAD protein modified form]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in increased expression of BAX protein]]; magnolol inhibits the reaction [trimethyltin results in increased expression of BAX protein]; rottlerin inhibits the reaction [trimethyltin results in increased expression of BAX protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]]; magnolol inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]; rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]]; rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in increased expression of CASP3 protein modified form]]; HR protein affects the reaction [trimethyltin results in increased activity of CASP3 protein]; magnolol inhibits the reaction [trimethyltin results in increased expression of CASP3 protein modified form]; rottlerin inhibits the reaction [trimethyltin results in increased expression of CASP3 protein modified form] trimethyltin results in increased expression of CASP3 mRNA; trimethyltin results in increased expression of CASP3 protein modified form
trimethyltin results in decreased expression of CYP11A1 mRNA trimethyltin results in decreased expression of and results in decreased activity of CYP11A1 protein
trimethyltin results in increased expression of GCLC mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLC mRNA]]; rottlerin promotes the reaction [trimethyltin results in increased expression of GCLC mRNA]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]]; rottlerin promotes the reaction [trimethyltin results in increased expression of GCLM mRNA]
trimethyltin results in increased expression of GFAP mRNA; trimethyltin results in increased expression of GFAP protein magnolol inhibits the reaction [trimethyltin results in increased expression of GFAP protein]
trimethyltin results in increased expression of HMOX1 protein magnolol inhibits the reaction [trimethyltin results in increased expression of HMOX1 protein] trimethyltin results in increased expression of HMOX1 mRNA
1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; [[trimethyltin chloride results in increased abundance of trimethyltin] which co-treated with Corticosterone] results in increased expression of HSD11B1 mRNA; [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased activity of HSD11B1 protein; [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; LY 290042 inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]]; SB 203580 inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]] [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA; Cortisone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; INS protein affects the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]
trimethyltin results in decreased expression of and results in decreased activity of HSD17B3 protein trimethyltin results in decreased expression of HSD17B3 mRNA
trimethyltin results in increased expression of IL6 mRNA; trimethyltin results in increased expression of IL6 protein IL6 results in decreased susceptibility to trimethyltin trimethyltin results in decreased expression of IL6 mRNA [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; 11-dehydrocorticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA; [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased secretion of IL6 protein; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Dexamethasone inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; INS1 protein inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; LY 290042 inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Resveratrol analog inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Spironolactone inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]]
INS1 protein inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]
[trimethyltin chloride results in increased abundance of trimethyltin] promotes the reaction [INS protein affects the expression of NEFH mRNA]; INS protein affects the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]
trimethyltin results in increased expression of ITGAM mRNA [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of ITGAM mRNA
trimethyltin results in increased phosphorylation of MAPK8 protein magnolol inhibits the reaction [trimethyltin results in increased phosphorylation of MAPK8 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein]]; rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein]; trimethyltin affects the localization of and results in increased activity of NFE2L2 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of NOS2 mRNA]; [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of NOS2 mRNA; magnolol inhibits the reaction [trimethyltin results in increased expression of NOS2 protein]; SB 203580 inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of NOS2 mRNA]
rottlerin inhibits the reaction [trimethyltin results in increased expression of and results in increased cleavage of PRKCD protein]; trimethyltin results in increased expression of and results in increased cleavage of PRKCD protein
[trimethyltin chloride results in increased abundance of trimethyltin] which affects the localization of RELA protein; Resveratrol analog inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which affects the localization of RELA protein]
trimethyltin results in increased expression of TNF mRNA trimethyltin results in increased secretion of TNF protein magnolol inhibits the reaction [trimethyltin results in increased secretion of TNF protein] [trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of TNF mRNA
browse the term
